Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
147
147 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- CAL101Phase 21 trial
Calluna Pharma AS · Idiopathic Pulmonary Fibrosis
- CHF 6001Phase 21 trial
Chiesi Farmaceutici S.p.A. · Asthma
- CHF10067Phase 21 trial
Chiesi Farmaceutici S.p.A. · Idiopathic Pulmonary Fibrosis
- CHF6333Phase 21 trial
Chiesi Farmaceutici S.p.A. · Bronchiectasis
- CMTX-101Phase 21 trial
Clarametyx Biosciences, Inc. · Persistent Infection, Cystic Fibrosis
- CSL787Phase 21 trial
CSL Behring · Non-cystic Fibrosis Bronchiectasis
- DIAG723Phase 21 trial
Diagonal Therapeutics, Inc. · Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension
- DWN12088DWN12088 XmgPhase 21 trial
Daewoong Pharmaceutical Co. LTD. · Idiopathic Pulmonary Fibrosis
- ENV-101taladegibPhase 21 trial
Endeavor Biomedicines, Inc. · Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
- ETD001Phase 21 trial
Enterprise Therapeutics Ltd · Cystic Fibrosis
- ETH47Phase 21 trial
Ethris GmbH · Asthma (Diagnosis)
- EXPD-101FXS7553Phase 21 trial
Expedition Therapeutics, Inc · Chronic Obstructive Pulmonary Disease (COPD)
- FB704APhase 21 trial
Oneness Biotech Co., Ltd. · Severe Asthma
- FrevecitinibPhase 21 trial
Kinaset Therapeutics Inc · Severe Asthma
- HRS-9821Phase 21 trial
Guangdong Hengrui Pharmaceutical Co., Ltd · COPD
- HSK50042Phase 21 trial
Haisco Pharmaceutical Group Co., Ltd. · Idiopathic Pulmonary Fibrosis (IPF)
- JKN2304Phase 21 trial
Joincare Pharmaceutical Group Industry Co., Ltd · COPD (Chronic Obstructive Pulmonary Disease), COPD
- JKN24011Phase 21 trial
Joincare Pharmaceutical Group Industry Co., Ltd · COPD (Chronic Obstructive Pulmonary Disease)
- JKN2403Phase 21 trial
Joincare Pharmaceutical Group Industry Co., Ltd · COPD (Chronic Obstructive Pulmonary Disease)
- KIT2014Phase 21 trial
Kither Biotech Srl · Chronic Obstructive Pulmonary Disease (COPD)
- linvemastatFP-020Phase 21 trial
Foresee Pharmaceuticals Co., Ltd. · Asthma (Diagnosis), Pulmonary Function, Moderate-to-Severe Asthma
- LQ036Phase 21 trial
Shanghai Novamab Biopharmaceuticals Co., Ltd. · Asthma
- LTI-03Phase 21 trial
Rein Therapeutics · Idiopathic Pulmonary Fibrosis (IPF)
- MTX-463Phase 21 trial
Mediar Therapeutics · Idiopathic Pulmonary Fibrosis
- ND-003Phase 21 trial
Shenzhen NewDEL Biotech, Co., Ltd · Idiopathic Pulmonary Fibrosis (IPF)
- NHS7108Phase 21 trial
Aimmune Nestlé Health Science US R&D, LLC · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality
- NSI-8226Phase 21 trial
Uniquity One (UNI) · Asthma
- ORJ-001Phase 21 trial
Oorja Bio, Inc. · Idiopathic Pulmonary Fibrosis
- PF-07868489Phase 21 trial
Pfizer · Pulmonary Arterial Hypertension
- PIPE-791Phase 21 trial
Contineum Therapeutics · Idiopathic Pulmonary Fibrosis
- RCT2100Phase 21 trial
ReCode Therapeutics · Cystic Fibrosis
- REGN13335Phase 21 trial
Regeneron · Pulmonary Arterial Hypertension (PAH)
- RESP302Phase 21 trial
Thirty Respiratory Limited · Non-Cystic Fibrosis Bronchiectasis
- RESP303Phase 21 trial
Thirty Respiratory Limited · Non-Cystic Fibrosis Bronchiectasis
- RIG-101Phase 21 trial
RIGImmune Inc. · Healthy Adult Participants, Asthma Exacerbation, Safety and Efficacy
- RO7275887Phase 21 trial
Roche (Genentech) · Chronic Obstructive Pulmonary Disease (COPD), Healthy Participants
- RO7830698Phase 21 trial
Roche (Genentech) · Chronic Obstructive Pulmonary Disease (COPD), Healthy Participants
- ROC-101Phase 21 trial
AllRock Bio, Inc. · Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension, Interstitial Lung Disease
- RSP-1502Phase 21 trial
Respirion Pharmaceuticals Pty Ltd · Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa
- RSS0343Phase 21 trial
Reistone Biopharma Company Limited · Chronic Obstructive Pulmonary Disease
- SB17170Phase 21 trial
SPARK Biopharma · IPF, Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)
- SHR4597Phase 21 trial
Guangdong Hengrui Pharmaceutical Co., Ltd · Asthma
- SPL84Phase 21 trial
SpliSense Ltd. · Cystic Fibrosis
- SV001Phase 21 trial
Shanghai Synvida Biotechnology Co.,Ltd. · Idiopathic Pulmonary Fibrosis(IPF)
- SYH2059Phase 21 trial
InnovStone Therapeutics Limited · Idiopathic Pulmonary Fibrosis
- SYH9061Phase 21 trial
CSPC-NBP Pharmaceutical Co., Ltd. · Idiopathic Pulmonary Fibrosis
- TQC3721Phase 21 trial
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Pulmonary Disease, Chronic Obstructive
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.